0000899243-22-035038.txt : 20221103 0000899243-22-035038.hdr.sgml : 20221103 20221103210631 ACCESSION NUMBER: 0000899243-22-035038 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221101 FILED AS OF DATE: 20221103 DATE AS OF CHANGE: 20221103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Berkman Charles S CENTRAL INDEX KEY: 0001392266 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 221359910 MAIL ADDRESS: STREET 1: 11085 NORTH TORREY PINES ROAD STREET 2: SUITE 300 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-11-01 1 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001392266 Berkman Charles S 3911 SORRENTO VALLEY BOULEVARD, SUITE 110 SAN DIEGO CA 92121 0 0 0 1 Former Executive Officer Common Stock 2022-11-01 4 D 0 11944 D 23825 D Employee Stock Option (right to buy) 90.68 2022-11-01 4 D 0 20126 D 2032-05-05 Common Stock 20126 0 D Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022. The stock option vests and is exercisable as to 12.5% of the underlying shares on August 5, 2022, and in 42 substantially equal monthly installments thereafter. /s/ Charles S. Berkman 2022-11-03